Locus Biosciences pulls in $35m
Locus Biosciences Inc, a clinical-stage biotechnology company, has raised $35 million in funding.
Locus Biosciences Inc, a clinical-stage biotechnology company, has raised $35 million in funding.
Copyright PEI Media
Not for publication, email or dissemination